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Background: High-throughput genetic testing is increasingly applied in clinics. Next-Generation Sequencing (NGS)
data analysis however still remains a great challenge. The interpretation of pathogenicity of single variants or
combinations of variants is crucial to provide accurate diagnostic information or guide therapies.
Methods: To facilitate the interpretation of variants and the selection of candidate non-synonymous polymorphisms
(nsSNPs) for further clinical studies, we developed BALL-SNP. Starting from genetic variants in variant call format (VCF)
files or tabular input, our tool, first, visualizes the three-dimensional (3D) structure of the respective proteins from the
Protein Data Bank (PDB) and highlights mutated residues, automatically. Second, a hierarchical bottom up clustering
on the nsSNPs within the 3D structure is performed to identify nsSNPs, which are close to each other. The modular
and flexible implementation allows for straightforward integration of different databases for pathogenic and benign
variants, but also enables the integration of pathogenicity prediction tools. The collected background information of
all variants is presented below the 3D structure in an easily interpretable table format.
Results: First, we integrated different data resources into BALL-SNP, including databases containing information on
genetic variants such as ClinVar or HUMSAVAR; third party tools that predict stability or pathogenicity in silico
such as I-Mutant2.0; and additional information derived from the 3D structure such as a prediction of binding
pockets. We then explored the applicability of BALL-SNP on the example of patients suffering from cardiomyopathies.
Here, the analysis highlighted accumulation of variations in the genes JUP, VCL, and SMYD2.
Conclusion: Software solutions for analyzing high-throughput genomics data are important to support diagnosis and
therapy selection. Our tool BALL-SNP, which is freely available at http://www.ccb.uni-saarland.de/BALL-SNP, combines
genetic information with an easily interpretable and interactive, graphical representation of amino acid changes
in proteins. Thereby relevant information from databases and computational tools is presented. Beyond this,
proximity to functional sites or accumulations of mutations with a potential collective effect can be discovered.Background
The study of non-synonymous polymorphisms (nsSNPs)
as genetic factors in human diseases and their contribu-
tion to phenotypic traits is essential in human healthcare.
Although only a small fraction of genetic variations cause
nsSNPs, over 85 % of such mutations are associated with a
specific disease [1]. NsSNPs can introduce premature stop
codons, consequently producing functionally incompetent* Correspondence: ack@bioinf.uni-sb.de
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nsSNPs frequently result in a single amino acid change
within a protein sequence and, thus, can alter protein
function comprising folding, stability, and binding of other
proteins or ligands.
The increasing adoption of Next-Generation Sequen-
cing (NGS) in clinical applications leads to a substantial
amount of novel nsSNPs. Since the experimental analysis
to gain knowledge concerning the pathogenicity of these
is laborious and time-consuming, computational ap-
proaches have been developed to predict the impact of an
amino acid substitution on protein function in silico [2, 3].rticle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
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) applies to the data made available in this article, unless otherwise stated.
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the pathogenic effect using statistical methods, machine
learning techniques, or protein evolution models, based
on features such as sequence homology, biochemical
properties, and structural information (hydrogen-bond
network, solvent accessibility, and so on). Besides, there
are computational methods based on potential energy
functions, force fields, and molecular dynamics, which
analyze the change in a protein’s stability, dynamics,
and interactions to consequently derive the impact of
an amino acid substitution [4, 5]. These methods, how-
ever, can also be time-consuming and are generally
used for small-scale investigations [6].
Beyond the influence of single mutations, we started
to study the influence of several nsSNPs in the same
protein, which may have a cumulative effect [7, 8]. From
a medical point of view, especially the individual com-
bination of nsSNPs may play a unique and crucial role
in clinical diagnostics, in particular, within the context of
complex genetic disorders. Since a protein’s structure, dy-
namics, and interactions are interrelated, nsSNPs may
change several properties of a protein simultaneously [9].
Besides many tumor entities, cardiovascular disorders
such as cardiomyopathies are known to be influenced by
numerous genetic variations and additional environmental
circumstances [10]. Thus, computational approaches able
to assess synergetic effects of multiple nsSNPs in one
single protein or in a complex of interacting proteins are
being currently developed.
To capture the relationship of multiple nsSNPs with
disease phenotypes, besides sequence features, structural
information is essential [7, 11]. The analysis of a collect-
ive effect of several mutations within one protein re-
quires information on their three-dimensional (3D)
environment and interaction. Are they located close to
each other? Do they change the hydrogen bond network
stabilizing the protein? Do they alter hydrophobicity and
charge steering a protein’s folding? Moreover, the 3D
location of substituted amino acids shed light on the
implied impact on the protein’s function: An exchange
of buried residues may, for example, affect protein stability
and folding, whereas mutations located on the protein
surface, close to putative binding sites can alter binding
affinities.
To address this, we developed BALL-SNP, a novel
tool based on the Biochemical Algorithms Library
(BALL) [12], a molecular modeling framework, which
provides robust and sophisticated algorithms on struc-
tural bioinformatics. BALL-SNP enables the assessment
of the functional impact of multiple nsSNPs in a single
protein by visualizing the mutated residues within a
wild type structure, performing a cluster analysis, and
supplementing it with the available information on the
pathogenicity of the nsSNPs from different databases[13, 14]. Additionally, putative binding pockets in the
protein structure, as well as protein stability changes
are predicted. Based on the generated information and
the 3D visualization, the user can hypothesize whether
the amino acid substitutions can produce a collective
effect due to mutual interaction or have an influence
on binding and stability. In consequence, candidate
nsSNPs for further studies can be selected.
Methods
Dataset
A valid and high-quality dataset is essential when analyz-
ing the phenotypic effect of nsSNPs on human health. We
analyzed a NGS dataset of 639 patients screened for the
full sequence of 76 genes, clinically relevant for dilated
cardiomyopathy (DCM) [15]. The dataset involves 842
nsSNPs. The sequencing was performed on IlluminaHiSeq
instruments. About 99.1 % of the targeted genomic region
was covered at least 50-fold. In consequence, the used
dataset is of high clinical quality.
According to available annotations in dbSNP [16],
SwissProt [17], and the Human Gene Mutation Database
(HGMD) [18], the DCM dataset comprises 192 benign-
labeled and 147 disease-linked nsSNPs. About 55 % of the
data have no available annotation information [7].
BALL-SNP
We introduced a new pipeline for the assessment of
multiple nsSNPs in NGS data. Our tool BALL-SNP is
based on the Biochemical Algorithms Library (BALL)
[12] and integrated in BALL’s visualization front-end
BALLView [19]. BALL is a comprehensive application
framework for rapid software prototyping, which offers a
large number of molecular data structures and algo-
rithms allowing for sophisticated development of new
approaches. Since we aim to combine genetic and struc-
tural information, while ensuring intuitive usability, we
take advantage of BALL’s rich functionality. We extended
the versatile C++ class library by adding functionality to
import and process variant call format (VCF)-based file
formats used in DNA sequencing and SNP calling. We
furthermore embedded the currently most important SNP
annotation databases and corresponding parsing methods.
In addition, we introduced a first version of a compute
server and the associated request functionality allowing
for straightforward integration of available prediction
tools. However, to be independent of the software
maintenance by a third party and to guarantee stable
performance, we only focus on the integration of avail-
able stand-alone software tools, installed on the created
compute server. Figure 1 outlines the BALL-SNP work-
flow along with all incorporated data sources.
Besides the 3D visualization, we display additional
generated information in an accessible HTML-based
Fig. 1 BALL-SNP workflow
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Moreover, as BALL-SNP is implemented on top of the
standard molecular modeling tool BALLView, an intuitive
and direct interaction of the user with the visualized 3D
structure representations is possible.
Results and discussion
Input formats
To ensure straightforward usability, we currently offer
two different input formats: an ANNOVAR-based input
[20], as well as a simple tab-separated format. Hence,
users are enabled to adopt the output obtained from
standard SNP calling software such as ANNOVAR
without substantial re-formatting, as well as use SNP
information from different sources compiled in a sim-
ple tab-separated input file. The ANNOVAR version
used for testing refers to the version from 12.11.2014.
We used the default parameters and set –buildver to
hg19.
BALL-SNP focuses on the analysis of the pathogenic
relevance of nsSNPs. The SNP calling process, however,
may have great influence on the results of the BALL-SNP
analysis. In consequence, the user should carefully adopt
the SNP calling parameters to his application purpose.
Since 3D structure information is essential for the
analysis of nsSNPs accumulated within one single pro-
tein, we automatically extract the PDB identifier of the
largest available 3D structure from UniProt [14]. The
chosen PDB structure, then is automatically loaded fromthe Protein Data Bank (PDB) [21]. To maintain flexibility,
we also provide the possibility to state a preferred PDB
identifier within both input formats or to specify a file
name with a user-built 3D model of the query protein.
Further input formats can easily be added.
Pathogenicity information
Experimentally gained knowledge about nsSNPs is depos-
ited and curated in different databases. Some of these
databases provide additional information concerning the
pathogenicity and clinical significance of a nsSNP. To
make use of this knowledge, we include information from
SwissProt/UniProt [14] and ClinVar [13] within BALL-
SNP. In particular, SwissProt/UniProt collects human
polymorphisms and disease mutations (annotated in the
HUMSAVAR document) assigned according to literature
reports on probable disease association. ClinVar is based
on the dbSNP [16] and reports human variations and
interpretations of the relationship of these variations to hu-
man health by providing clinical significance information.
Currently, we are focusing on selected important
databases that report nsSNP pathogenicity. The embedded
database module, however, can easily be extended to in-
clude further databases and annotation sources.
Predicting binding pockets
In addition to known information on pathogenicity from
databases and in silico prediction, further information
may provide clinicians essential input. Among these, the
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pockets for ligands plays a crucial role. BALL-SNP pre-
dicts active sites, which often are located in the largest
surface cleft, based on the Putative Active Sites with
Spheres (PASS) method [22], that use probe spheres to
characterize regions of buried volume on a protein
surface. Based on size, shape, and burial extent of these
volumes, positions, which putatively represent binding
sites, are identified. The predicted active sites are visu-
alized as spheres in BALL-SNP, which represent their
centers.Protein stability change
Proteins properly folded have minimal potential energy
and are usually stable. Amino acid substitutions intro-
ducing a change in the protein sequence can have a sig-
nificant impact on the potential energy of the protein
structure, and thus its folding and stability. Consequently,
the analysis to which extent a mutation affects protein
stability with respect to the wild type, extends the under-
standing of the mutation impact on protein function and
the genotype-phenotype relationship, accordingly.
Several methods to predict the change of a protein’s
binding free energy exist [5, 23]. Since I-Mutant was
shown to have better performance compared to other
tools [24], we set up a compute server running freely
available I-Mutant 2.0 code [25]. I-Mutant 2.0 automat-
ically predicts protein stability changes caused by single
point mutations in protein sequence using support vec-
tor machines (SVMs). BALL-SNP offers the possibility
to send a request to this server to calculate the protein
stability changes. Since the computation time increases
with the number of nsSNPs in the input file, users can
decide whether to generate and include this informa-
tion or just focus on the remaining information.Fig. 2 Cutout of the solvent-excluded surface of JUP. The purple
sphere represents the center of a predicted binding site. The nsSNP
L527I (highlighted in yellow) is located within the detected, putative
binding pocketCluster analysis of nsSNPs
Several mutated residues in one protein may have a
synergetic effect on the cause and severity of a disease
phenotype. The detection of putative quantitative effects
requires 3D structural information and visualization. To
support the visual inspection of spatial relations, we im-
plemented a hierarchical bottom-up clustering performed
on the 3D structure and the included nsSNPs. The applied
distance metric refers to the Euclidean distance of the
mutated residues’ C-alpha atoms. The linkage criterion to
determine the distance between sets of nsSNPs was de-
fined according to the average linkage variant. The results
of the cluster analysis are represented in tabular format on
BALL-SNP’s information page. Within the 3D structure
visualization the clustering nsSNPs can be labeled accord-
ing to their cluster affiliation.Analysis of DCM data with BALL-SNP
To avoid artifacts, that may arise from using artificially
generated datasets and to prove the benefits of the
developed tool BALL-SNP, we applied it to the high-
quality NGS dataset of 639 DCM patients.
There are two practical scenarios based on NGS data,
which are, to the best of our knowledge, not implemented
in the previously existing methods: the assessment of the
effect of several nsSNPs within in a single protein, and the
contribution of one or more nsSNPs to ligand binding or
protein stability. BALL-SNP is able to support the user in
selecting candidate nsSNPs for further analysis and finding
possible solutions in both scenarios. Within the under-
lying cardiomyopathy dataset, we identified three cases
exemplary for both of them. Genes JUP,VCL, and SMYD2
revealed nsSNP clusters in potentially interesting loca-
tions. In particular, the nsSNPs of the DCM data within
these genes reveal no pathogenic annotations. The in-
put files for these genes can be downloaded from the
BALL-SNP homepage ([26]).
Contribution of nsSNPs on protein binding
The gene JUP coding for junction plakoglobin is involved
in cell junction, which influence the arrangement and
function of cells within a tissue. In particular, JUP is
involved in arrhythmogenic right ventricular dysplasia
(ARVD), a congenital heart disease [27]. The nsSNPs in
our dataset, identified in the coding region of JUP
obtained either no annotation, or were annotated as
benign. However, using BALL-SNP, we are able to iden-
tify a change in protein stability upon mutation corre-
sponding to several previously unknown nsSNPs. Since
the majority of detected nsSNPs within JUP have been
predicted to induce a decrease in protein stability, they
can contribute to dysfunction. Moreover, nsSNP L527I
is located within a predicted binding site (Fig. 2). As a
Fig. 3 Chain A of protein VCL. The wild type structure of the protein
VCL is displayed in the so-called cartoon representation (gray). The
mutated residues, clustering in the structure, are colored in orange
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involved in the observed phenotype due to modification
of the protein ligand binding.nsSNP cluster
VCL codes for vinculin, an actin filament-binding pro-
tein, involved in both, cell-matrix and cell-cell adhesion.
VCL has been reported to be associated with dilatedFig. 4 Cutouts of the protein structure of SMYD2. The clustering pairs of n
close-up views of the correspondingly colored nsSNP pairs. All pairs are loccardiomyopathy, a congestive heart failure [28]. Database
search yields no annotations for the nsSNPs in VCL
from our dataset. Interestingly, BALL-SNP identifies,
that amino acids corresponding to nsSNPs, cluster to-
gether in the protein structure (Fig. 3). The nsSNPs
R230H, A922V, and H363R, R759Q cluster pairwise
with a C-alpha atom distance around 19 Å. In addition,
all of these nsSNPs are predicted to decrease protein
stability. Interestingly, the nsSNPs I519L, R586W, and
V658A cluster with C-alpha atom distances between 15
to 19 Å, and the latter increases protein stability, in
contrast to I519L and R586W.
The most prominent example of the cumulative effect
of several nsSNPs within our dataset refers to SMYD2,
coding for a N-lysine methyltransferase, which methyl-
ates both, histones and non-histone proteins. While the
database search only returns either no or benign annota-
tions, BALL-SNP impressively shows that several nsSNP
pairs are located next to each other, implying a cumulative
effect. The nsSNPs Y370C and M384V (at a C-alpha atom
distance of 9 Å) are adjacent in an opposite direction, and
both are predicted to lead to decreased protein stability.
Furthermore, the mutations G394C and I430M are
located close to each other (12 Å C-alpha atom distance)
as well as V301I and V349A (16 Å C-alpha atom distance).
Interestingly, both pairs produce opposite predictions
concerning their impact on protein stability. Their loca-
tion next to each other may have a compensating effect
on protein stability, since one partner putatively de-
creases while the other increases it. Figure 4 illustrates
these 3D observations, in detail. The overall results of
the hierarchical cluster analysis based on average link-
age are shown in Fig. 5.sSNPs are highlighted in different colors. The color framed pictures are
ated next to each other, indicating a cumulative effect
Fig. 5 Cluster analysis of the nsSNPs in SMYD2. SMYD2 consists of two chains, (a) and (b). Hence, the nsSNPs are labeled accordingly. a The
nsSNPs are highlighted within the protein 3D structure according to their cluster affiliation. b The overall cluster analysis results are shown in
tabular format on the information page. The red marked distance refers to the highlighted cluster of nsSNPs in the structural visualization
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analysis of amino acid substitutions corresponding to
nsSNPs within a protein. The presented results certainly
require further analysis and experimental validation,
however, they reveal the power of BALL-SNP to capture
mutual relations and spatial traits of nsSNPs and recover
functional features, not available in databases. In medical
application, a proper selection of candidate nsSNPs for
further analysis can save costs and time. BALL-SNP de-
finitively can support this essential step.
Our tool BALL-SNP combines genetic and structural in-
formation to provide scientists the possibility to get deeper
insights on the potential effects of accumulated mutations
in proteins. We intend to add further functionality in the
future development of our tool to overcome some
(current) downsides. Often information from databases is
not available. Hence, we plan to make use of other existing
tools to predict the functional impact of single nsSNPs.
Several tools for the pathogenicity prediction of nsSNPs
are available. However, the underlying databases andresources exceed the portable size of a downloadable,
freely available software tool with a comprehensive mo-
lecular modeling library, such as BALL-SNP. Further-
more, the required input formats as well as the obtained
output are often incompatible among the tools and thus, a
combination of different prediction tools requires add-
itional analysis. We were able to show in a recent study
[7] that prediction accuracy and sensitivity can be further
improved calculating a sophisticated consensus score for
each single nsSNP. We will extend the created compute
server with functionality to calculate the prediction results
of selected pathogenicity tools as well as a defined consen-
sus score based on the single prediction results.
BALL-SNP currently relies on the 3D information de-
posited in the PDB. Unfortunately, the gap between
known protein sequences and available 3D protein
structures is still huge. To solve this problem, we will
add the possibility to automatically search for templates
and create molecular models for proteins without an
available structure in the PDB.
Mueller et al. Genome Medicine  (2015) 7:65 Page 7 of 8Since BALL enables explicit solvent molecular dynam-
ics (MD) simulations and different docking scenarios, we
additionally aim to integrate other functionality and
workflows for therapeutic use, such as the analysis of
drug target binding.
Since BALL-SNP is an open source project and due to
its modular architecture, it is easily extendable and adapt-
able to include further databases and third party tools,
even by other experienced users.
Conclusion
The analysis of the genotype-phenotype relation and in
particular, of the influence of nsSNPs on protein stability
and function, is essential in human healthcare. In spite
of the fact that the majority of common diseases such as
cardiomyopathy are caused by accumulation of several
nsSNPs, computational methods to analyze cumulative
nsSNPs and their putative quantitative contribution to
an observed pathogenic phenotype are missing. In con-
sequence, the validation of the clinical relevance of
nsSNP spatial interactions is limited.
Here, we present a novel, freely available software tool,
BALL-SNP, which enables the assessment of the impact of
nsSNP clusters on protein stability, and consequently
assists the selection of candidate nsSNPs for experimental
validation. Since both, genetic and structural information
is crucial for analysis of the influence of nsSNPs on phe-
notypes. BALL-SNP is based on a standard molecular
modeling framework, allows the use of standard NGS out-
put, and embeds important nsSNP annotation databases.
Though further improvement is needed to meet re-
quirements of the clinical application, BALL-SNP already
makes an important contribution to the existing instru-
ments of candidate nsSNP analysis.
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